The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 dose-escalation, dose-expansion trial of intratumoral HER2- and HER3-primed dendritic cells injections for the treatment of early-stage TNBC and HR low positive breast cancer: DecipHER trial.
 
Ricardo L Costa
Stock and Other Ownership Interests - Dare Bioscience; Spero Therapeutics
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Pfizer; Sermonix Pharmaceuticals
 
Jennifer A Childress
No Relationships to Disclose
 
Edith Abraham
No Relationships to Disclose
 
Carly Farrell
No Relationships to Disclose
 
Qianxing Mo
No Relationships to Disclose
 
Zena Jameel
No Relationships to Disclose
 
Aixa Elena Soyano Muller
Honoraria - FLASCO; OncLive/MJH Life Sciences
Consulting or Advisory Role - Lilly; Novartis
 
Kimberley T Lee
No Relationships to Disclose
 
Susan Hoover
No Relationships to Disclose
 
John Kiluk
No Relationships to Disclose
 
Robert J Weinfurtner
No Relationships to Disclose
 
Marie Catherine Lee
Leadership - Medtronic (I)
Research Funding - Elucent Medical
Travel, Accommodations, Expenses - Amgen
 
Christine Laronga
Patents, Royalties, Other Intellectual Property - Royalties for reviewing
 
Nazanin Khakpour
No Relationships to Disclose
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Immunomedics; Immunomedics/Gilead; Novartis
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)
 
Hung T. Khong
Stock and Other Ownership Interests - agenus; Lipocine; MEI Pharma; MustangBio; TG Therapeutics; Tiziana Life Sciences; Vaxart
Consulting or Advisory Role - Celcuity
Research Funding - AstraZeneca
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Merck
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Brian J. Czerniecki
Research Funding - Turnstone Bio
Patents, Royalties, Other Intellectual Property - ImmunoRestoration